Prime Medicine Inc (PRME)
6.495
-0.43
(-6.21%)
USD |
NASDAQ |
May 28, 16:00
6.495
0.00 (0.00%)
After-Hours: 16:17
Prime Medicine Cash and Short Term Investments (Quarterly): 210.72M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 210.72M |
| December 31, 2023 | 121.66M |
| September 30, 2023 | 165.32M |
| June 30, 2023 | 207.62M |
| March 31, 2023 | 249.52M |
| Date | Value |
|---|---|
| December 31, 2022 | 293.92M |
| September 30, 2022 | 146.66M |
| June 30, 2022 | 180.60M |
| December 31, 2021 | 269.62M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
121.66M
Minimum
Dec 2023
293.92M
Maximum
Dec 2022
205.07M
Average
207.62M
Median
Jun 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Verve Therapeutics Inc | 606.37M |
| PetMed Express Inc | 49.44M |
| 10x Genomics Inc | 371.81M |
| Sana Biotechnology Inc | 311.08M |
| Recursion Pharmaceuticals Inc | 296.33M |